p16 promoter methylation in premature rats with chronic lung disease induced by hyperoxia

( views:153, downloads:0 )
Author:
YUE Xiao-hong()
FU Jian-hua(Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China)
XUE Xin-dong(Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China)
Journal Title:
CHINESE JOURNAL OF PERINATAL MEDICINE
Issue:
Volume 14, Issue 08, 2011
DOI:
10.3760/cma.j.issn.1007-9408.2011.08.004
Key Word:
Hyperoxia;Lung diseases;Genes, p16;Promoter regions ( genetics );Methylation;Infant, premature;Rats

Abstract: Objective To investigate p16 promoter methylation in premature rats with chronic lung disease induced by hyperoxia. Methods Eighty premature Wistar rats were randomly divided into two groups: hyperoxia group (fraction of inspiratory oxygen) 0. 90 and control group (fraction of inspiratory oxygen 0. 21), 40 rats for each group. Semi-nested methylation specific polymerase chain reaction and methylation specific polymerase chain reaction were applied respectively to detect p16 promoter methylation in lung tissues. Additionally, p16 mRNA and protein expressions in lung tissue were detected by reverse transcription- polymerase chain reaction, Western blot and immunohistochemistry method. Results The methylation was not found in control group by seminested methylation specific polymerase chain reaction and methylation specific polymerase chain reaction, while was found in different aged rats of the hyperoxia group. The methylation detection rate was higher by using the semi-nested methylation-specific polymerase chain reaction (52.5%, 21/40) than that by methylation specific polymerase chain reaction (42.5%, 17/40) in the hyperoxia group,but there was no statistically significant difference between the two methods. The p16 mRNA in the hyperoxia group were significantly lower than in the control group at day 7, 14 and 21(1.73 ± 0.40 vs 2.11±0. 37,1.29±0. 19 vs 1.60±0. 27,0. 95±0.25 vs 1.72±0. 34, t=2.19, 2.95 and 10. 43,P<0. 05). The p16 protein expressions by western blot in the hyperoxia group were significantly lower than in the control group at day 7, 14 and 21 also (88. 1±8. 7 vs 95.0±4.1,65.7±4.5 vs 83. 5±13.6 and 50.4±4.9 vs 86.7±11.9, t=2.27,3.95 and 13.40,P<0.05). The expression of p16 mRNA (1.06±0.61) and protein (62.32±25.65) in lung tissues of rats with methylation was lower than that without methylation (1.63±0.62 and 94.93±22.21, respectively) (t=2.95, OR=0. 86;t=4.28, OR=0. 85,P<0.01, respectively). Conclusions Exposure to hyperoxia might induce p16 promoter methylation in lung tissues in premature rats. Methylation risk increases as exposure time extends. p16 promoter methylation induced by hyperoxia might participate in the mechanism of lowering p16 mRNA and protein expression, but might not result in p16 gene silence.

  • [1]Zhang K,Zhang R,Li X,et al.The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis.Clin Exp Dermatol,2007,32:702-708.
  • [2]Chen M,Chen ZQ,Cui PG,et al.The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance.Br J Dermatol,2008,158:987-993.
  • [3]Chang H,Yi B,Li L,et al.Methylation of tumor associated genes in tissue and plasma samples from liver disease patients.Exp Mol Pathol,2008,85:96-100.
  • [4]GodoyAE,Mandelli J,Oliveira FH,et al.p16INK4 expression in precursor lesions of squamous cell cervical cancer related to the presence of HPV-DNA.Braz J Med Biol Res,2008,41:583-588.
  • [5]Lam AK,Ong K,Giv MJ,et al.p16 expression in colorectal adenocarcinoma:marker of aggressiveness and morphological types.Pathology,2008,40:580-585.
  • [6]Hall GL,Shaw RJ,Field EA,et al.p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia.Cancer Epidemiol Biomarkers Prev,2008,17:2174-2179.
  • [7]李红文,雍磊,高歌,等.银屑病角质形成细胞p16基因微卫星杂合性缺失研究.中华皮肤科杂志,2004,37:138-140.
  • [8]Lee TL,Leung WK,Chan MW,et al.Delection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.Clin Cancer Res,2002,8:1761-1766.
  • [9]Bian YS,Osterheld MC,Fontolliel C,et al.p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in barrett's esophagus.Gastroenterology,2001,122:1113-1121.
  • [10]Baylin SB,Herman JG.DNA hypermethylation in tumorigensis:epigenetics joine genetics.Trends Genet,2000,16:168-174.
  • [11]苏长青,单祥年.CDKN 2/p16基因甲基化失活与肺癌关系的研究.中华医学遗传学杂志,2000,17:36-38
  • [12]富建华,薛辛东.慢性肺疾病早产鼠转化生长因子β1基因和蛋白动态表达及其对肺发育的抑制作用.中华儿科杂志,2005,43:463-465.
  • [13]Frank L.Protective effect of keratinocyte growth factor against lung abnormalities associated with hyperoxia in prematurely born rats.Biol Neonate,2003,83:263-272.
  • [14]Larid PW,Jaenisch R.The role of DNA methylation in cancer genetic and epigenetics.Annu Res Genet,1996,30:441.
  • [15]Mucluskey L,Chen C,Delgadillo E,et al.Differences in p16 gene methylation and expression in benign and malignant ovarian tumor.Gynecol Oncol,1999,72:87-92.
  • [16]Robertson KD.DNA methylation,methyltransferases,and cancer.Oncogene,2001,20:3139-3155.
  • [17]Jones PA,Takai D.The role of DNA methylation in mammalian epigenetics.Science,2001,293:1068-1070.
  • [18]Zochbauer Muller S,Fong KM,Virmani AK,et al.Aberrant promoter methylation of multiple genes in non-small cell lung cancers.Cancer Res,2001,61:249-255.
  • [19]LamyA,Sesboue R,Bouiguignon J,et al.Aberrantmethlation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions:a prospective study in high-risk patients without invasive cancer.Int J Cancer,2002,100:189-193.
  • [20]Jost JP,Jost YC.Transient DNA demethylation in differentiating mouse myoblasts correlates with higher activity of 5methyldeoxycytidine excision repair.J Biol Chem,1994,269:10040-10043.
  • [21]Hobbs CA,Paul BA,Gilmour SK,et al.Elevated levels of polyamines alter chromatin in murine skin and tumors without global changes in nucleosome acetylation.Exp Cell Res,2003,290:427-436.
  • [22]Ladiges W,Wiley J,MacAuley A.Polymorphisms in the DNA repair gene XRCC1 and age-related disease.Mech Ageing Dev,2003,124:27-32.
  • [23]An Q,Liu Y,Gao Y,et al.Detection of p16 hypermethylation in circulating plasma DNA of non small cell lung cancer patients.Cancer Lett,2002,188:109-114.
  • [24]沈佳尧,侯鹏,祭美菊,等.半巢式甲基化特异性聚合酶链反应在胃癌p16基因甲基化检测中的应用.中华检验医学杂志,2004,27:85-88.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn